INT1921

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.78
First Reported 1979
Last Reported 2010
Negated 6
Speculated 1
Reported most in Body
Documents 47
Total Number 49
Disease Relevance 43.23
Pain Relevance 2.53

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

plasma membrane (CEACAM7)
Anatomy Link Frequency
colon 3
liver 2
lung 2
lymph nodes 1
spindle cells 1
CEACAM7 (Homo sapiens)
Pain Link Frequency Relevance Heat
Regional anesthesia 2 99.56 Very High Very High Very High
Somatostatin 1 99.20 Very High Very High Very High
headache 1 94.84 High High
imagery 39 94.16 High High
pain flank 4 93.64 High High
alcohol 1 92.64 High High
Pain 25 90.24 High High
Chronic pancreatitis 5 88.20 High High
cva 8 87.36 High High
abdominal pain 6 86.64 High High
Disease Link Frequency Relevance Heat
Cancer 1383 100.00 Very High Very High Very High
Disease 311 100.00 Very High Very High Very High
Adenocarcinoma 101 100.00 Very High Very High Very High
Lung Cancer 96 100.00 Very High Very High Very High
Pox Virus Infection 82 100.00 Very High Very High Very High
Pressure And Volume Under Development 24 100.00 Very High Very High Very High
Liver Disease 6 99.96 Very High Very High Very High
Advanced Or Metastatic Breast Cancer 20 99.84 Very High Very High Very High
Malignant Neoplastic Disease 139 99.76 Very High Very High Very High
Colon Cancer 693 99.52 Very High Very High Very High

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
We report a case of carcinoembryonic antigen (CEA)-producing renal pelvic and ureteral cancer.
Gene_expression (producing) of CEA associated with ureteral neoplasms
1) Confidence 0.78 Published 2003 Journal Hinyokika Kiyo Section Abstract Doc Link 12696186 Disease Relevance 0.61 Pain Relevance 0.09
Prostate-specific antigen (PSA) and prostatic acid phosphatase (PAP) are well known as specific tumor markers of prostate cancer, but carcinoembryonic antigen (CEA)- and carbohydrate antigen 19-9 (CA19-9)-producing adenocarcinoma originating in the prostate is rare.
Gene_expression (producing) of CEA associated with adenocarcinoma, cancer and prostate cancer
2) Confidence 0.66 Published 1999 Journal Urol. Int. Section Abstract Doc Link 10738193 Disease Relevance 0.97 Pain Relevance 0.08
Serum tissue polypeptide antigen (TPA) and plasma carcinoembryonic antigen (CEA) were simultaneously measured in 108 patients with breast cancer, in 40 healthy women, and in 26 women with benign breast disease.
Gene_expression (measured) of CEA in plasma associated with breast disease and breast cancer
3) Confidence 0.65 Published 1979 Journal J. Natl. Cancer Inst. Section Abstract Doc Link 292806 Disease Relevance 0.54 Pain Relevance 0
INVESTIGATIONS: Laboratory findings were elevated levels of serum alkaline phosphatase (AP), CA 19-9 and CEA.
Gene_expression (levels) of CEA
4) Confidence 0.65 Published 2006 Journal Dtsch. Med. Wochenschr. Section Body Doc Link 17091439 Disease Relevance 0.10 Pain Relevance 0
Overall, there was no significant correlation between SNCG protein expression and age, tumor size, tumor differentiation, depth of invasion, TNM stage, and preoperative serum CEA levels.
Gene_expression (expression) of CEA associated with cancer
5) Confidence 0.62 Published 2010 Journal BMC Cancer Section Body Doc Link PMC2912867 Disease Relevance 1.71 Pain Relevance 0
There were 42% (45/108) of patients with elevated CEA levels in the SNCG negative group, rates of DFS and OS of these patients were 43% and 39% at 5 year after surgery.
Gene_expression (levels) of CEA
6) Confidence 0.62 Published 2010 Journal BMC Cancer Section Body Doc Link PMC2912867 Disease Relevance 0.57 Pain Relevance 0
Serum levels of CEA, CA 19-9, and proGRP were high. 67Gallium scintigraphy showed an accumulation of radioactivity at the hilum of the right lung, and the findings of bronchofiberscopy were compatible with the diagnosis of small cell lung cancer.
Gene_expression (levels) of CEA in lung associated with lung cancer
7) Confidence 0.60 Published 1998 Journal Nihon Kokyuki Gakkai Zasshi Section Abstract Doc Link 9866984 Disease Relevance 0.53 Pain Relevance 0.09
Both serum levels of CEA and CA19-9 were elevated to 36.9 ng/ml and 119 u/ml, respectively.
Gene_expression (levels) of CEA
8) Confidence 0.60 Published 2003 Journal Hinyokika Kiyo Section Abstract Doc Link 12696186 Disease Relevance 0.83 Pain Relevance 0.09
Immunohistochemical study showed that malignant cells were positive for CEA.
Gene_expression (positive) of CEA associated with malignant neoplastic disease
9) Confidence 0.59 Published 1989 Journal Aust N Z J Surg Section Abstract Doc Link 2684122 Disease Relevance 0.97 Pain Relevance 0.09
His serum CEA level was 104.1 ng/mL.
Gene_expression (level) of CEA
10) Confidence 0.59 Published 2009 Journal Gan To Kagaku Ryoho Section Abstract Doc Link 19755827 Disease Relevance 0.67 Pain Relevance 0.09
Immunohistochemically, the tumor cells of the epithelial component were positive for embryonal membrane antigen (EMA), carcinoembryonic antigen (CEA), human mesothelial cells (HBME)-1, and cytokeratin, and the spindle cells were positive for vimentin.
Gene_expression (positive) of CEA in spindle cells associated with cancer
11) Confidence 0.58 Published 2002 Journal Med Electron Microsc Section Abstract Doc Link 12181652 Disease Relevance 0.63 Pain Relevance 0.12
In this case, CEA monitoring was not useful for early detection of anastomotic recurrence.
Gene_expression (monitoring) of CEA associated with recurrence
12) Confidence 0.57 Published 2007 Journal World J Surg Oncol Section Body Doc Link PMC1994957 Disease Relevance 1.56 Pain Relevance 0.08
In some cases of pancreatic cancer with elevated serum CEA, ferritin and BMG, only CEA was positive in cancer cells, indicating that CEA is produced from cancer cells while ferritin and BMG are not produced from them.
Gene_expression (produced) of CEA associated with cancer and pancreatic cancer
13) Confidence 0.56 Published 1983 Journal Gan To Kagaku Ryoho Section Abstract Doc Link 6349542 Disease Relevance 1.12 Pain Relevance 0.08
Using a four-marker gene-panel (mam, PIP, CEA, and PSE) at the threshold of three standard deviations above the mean expression level in normal control samples for each gene, 19 patients (11%) out of 177 were positive.
Gene_expression (expression) of CEA
14) Confidence 0.55 Published 2008 Journal BMC Cancer Section Body Doc Link PMC2292197 Disease Relevance 0.26 Pain Relevance 0
Using the five-marker gene-panel (mam, PIP, CEA, PSE and EpCAM) at the threshold of three standard deviations above the mean expression level in normal control samples for each gene, 136 (63%) patients out of 215 were positive for at least one marker.
Gene_expression (expression) of CEA
15) Confidence 0.55 Published 2008 Journal BMC Cancer Section Body Doc Link PMC2292197 Disease Relevance 0.47 Pain Relevance 0
The expression of carcinoembryonic antigen (CEA) and lysozyme were also determined.
Spec (determined) Gene_expression (expression) of CEA
16) Confidence 0.54 Published 1990 Journal Cancer Section Abstract Doc Link 2224768 Disease Relevance 0.93 Pain Relevance 0.28
Figure 2 illustrates that 170 patients with SNCG positive (A), CEA positive (B), and either SNCG or CEA positive (C) all show significantly poorer survival rates than those with the corresponding negative markers (P = 0.001, <0.0001, <0.0001, respectively).
Gene_expression (positive) of CEA
17) Confidence 0.54 Published 2010 Journal BMC Cancer Section Body Doc Link PMC2912867 Disease Relevance 0.42 Pain Relevance 0
SNCG overexpression correlates with poor outcome and remains an independent prognostic indicator for patients with normal preoperative serum CEA level
Gene_expression (level) of CEA
18) Confidence 0.54 Published 2010 Journal BMC Cancer Section Body Doc Link PMC2912867 Disease Relevance 0.61 Pain Relevance 0
As expected, clinicopathologic features including TNM stage (P < 0.0001), lymph node metastasis (P < 0.0001), depth of invasion (P = 0.011), preoperative serum CEA levels (P = 0.001) significantly influenced recurrence of colon adenocarcinoma, whereas intravascular embolus, histological differentiation, gender, age, and tumor size didn't affect recurrence of tumors (P > 0.05).
Gene_expression (levels) of CEA in colon associated with cancer, embolism, colon cancer, recurrence and metastasis
19) Confidence 0.54 Published 2010 Journal BMC Cancer Section Body Doc Link PMC2912867 Disease Relevance 2.20 Pain Relevance 0
Correlations between SNCG levels and patient clinicopathologic characteristics, CEA levels were performed using Pearson chi-square test.
Gene_expression (levels) of CEA
20) Confidence 0.54 Published 2010 Journal BMC Cancer Section Body Doc Link PMC2912867 Disease Relevance 0.45 Pain Relevance 0

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox